These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 12481524)

  • 21. Health technology assessment.
    Hailey D
    Singapore Med J; 2006 Mar; 47(3):187-92; quiz 193. PubMed ID: 16518551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of NICE technology appraisal in NHS rationing.
    Walker S; Palmer S; Sculpher M
    Br Med Bull; 2007; 81-82():51-64. PubMed ID: 17409119
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The National Institute for Health and Clinical Excellence and its role in assessing the value of new cancer treatments in England and Wales.
    Trowman R; Chung H; Longson C; Littlejohns P; Clark P
    Clin Cancer Res; 2011 Aug; 17(15):4930-5. PubMed ID: 21791636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
    Foy JM; Earls MF
    Pediatrics; 2005 Jan; 115(1):e97-104. PubMed ID: 15629972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic barriers to implementation of innovations in health care: is the long run-short run efficiency discrepancy a paradox?
    Adang EM; Wensing M
    Health Policy; 2008 Dec; 88(2-3):236-42. PubMed ID: 18471924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Key principles for the improved conduct of health technology assessments for resource allocation decisions.
    Drummond MF; Schwartz JS; Jönsson B; Luce BR; Neumann PJ; Siebert U; Sullivan SD
    Int J Technol Assess Health Care; 2008; 24(3):244-58; discussion 362-8. PubMed ID: 18601792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Technology assessment, coverage decisions, and conflict: the role of guidelines.
    Sheingold SH
    Am J Manag Care; 1998 Sep; 4 Spec No():SP117-25. PubMed ID: 10185988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NICE's use of cost effectiveness as an exemplar of a deliberative process.
    Culyer AJ
    Health Econ Policy Law; 2006 Jul; 1(Pt 3):299-318. PubMed ID: 18634698
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biostatistical aspects for the use of evidence based medicine in health technology assessment.
    Freemantle N
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():31-43. PubMed ID: 18987906
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Conditions for introduction and financing of new technologies].
    Rutten FF; Grijseels EW
    Ned Tijdschr Geneeskd; 1999 Nov; 143(45):2229-32. PubMed ID: 10578419
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stochastic league tables: an application to diabetes interventions in the Netherlands.
    Hutubessy RC; Niessen LW; Dijkstra RF; Casparie TF; Rutten FF
    Health Econ; 2005 May; 14(5):445-55. PubMed ID: 15386648
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Technology assessment in the German context.
    Drummond M
    Eur J Health Econ; 2007 Sep; 8 Suppl 1():S3. PubMed ID: 17619919
    [No Abstract]   [Full Text] [Related]  

  • 34. Federal initiatives to support rapid learning about new technologies.
    Tunis SR; Carino TV; Williams RD; Bach PB
    Health Aff (Millwood); 2007; 26(2):w140-9. PubMed ID: 17259196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of cost-effectiveness analysis in health care decision-making.
    Magel JS
    Physician Exec; 1990; 16(3):31-2. PubMed ID: 10113233
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The NHS as an insurer.
    Vaithianathan R; Lewis G
    J Health Serv Res Policy; 2010 Jul; 15(3):171-3. PubMed ID: 20203080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Criteria and procedures for determining benefit packages in health care. A comparative perspective.
    Gress S; Niebuhr D; Rothgang H; Wasem J
    Health Policy; 2005 Jul; 73(1):78-91. PubMed ID: 15911059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medical technology management: bridging the gap between theory and practice.
    Shemer J; Abadi-Korek I; Seifan A
    Isr Med Assoc J; 2005 Apr; 7(4):211-5. PubMed ID: 15847198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Opportunity costs and local health service spending decisions: a qualitative study from Wales.
    Karlsberg Schaffer S; Sussex J; Hughes D; Devlin N
    BMC Health Serv Res; 2016 Mar; 16():103. PubMed ID: 27012523
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.